Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study-Reference-Cited by-同舟云学术

Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study

Published:2005-04 Issue:4 Volume:1 Page:351-356
ISSN:1176-6344
Container-title:Vascular Health and Risk Management
language:en
Short-container-title:Vascular Health and Risk Management

Author:

Patel Jeetesh V,Gupta Sandeep,Lie Frank,Hughes Elizabeth A

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health,Hematology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference19 articles.

1. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

2. An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor

3. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Burden of Atherosclerotic Cardiovascular Disease in South Asians Residing in Canada: A Reflection From the South Asian Heart Alliance;CJC Open;2019-11

2. Safety of atorvastatin in Asian patients within clinical trials;Cardiovascular Therapeutics;2016-11-12

3. Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions;World Journal of Cardiology;2016

4. Effectiveness of Statin Prescribing on Reducing Mortality in South Asian, Chinese, and White Patients With Diabetes;Canadian Journal of Cardiology;2013-08

5. Statin dose in Asians: is pharmacogenetics relevant?;Pharmacogenomics;2011-11